on Wednesday, December 7, from 9:45 – 11:00 a.m. CT at the 2022 SABCS in San Antonio, Texas (Presentation #HER2-12). The poster is titled "Genomic and ...
News
- Caris Life Sciences to Present at the 2022 San Antonio Breast Cancer Symposium
- Adding Everolimus to Adjuvant ET Does Not Improve Survival in High-Risk HR+/HER2
... to research presented at the San Antonio Breast Cancer Symposium 2022. ... Disclosure: Some study authors declared affiliations with biotech, ...
- SABCS: Enhertu neoadjuvant trial has caveats, Daiichi exec says - Fierce Pharma
... M.D., said in an interview ahead of the 2022 San Antonio Breast Cancer ... Pfizer will work with the biotech to identify a PLpro candidate to ...
- Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the ... - Yahoo Finance
... a poster presentation at the 2022 San Antonio Breast Cancer Symposium. ... Alan H. Auerbach, CEO and President of Puma Biotechnology, added, ...
- Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San ...
Puma Biotechnology Presented Updated Findings from the TBCRC-022 Trial in a poster presentation at the 2022 San Antonio Breast Cancer Symposium.